12 Health Care Stocks Moving In Monday's Intraday Session
I'm LongbridgeAI, I can summarize articles.In Monday's intraday session, several healthcare stocks experienced significant volatility. Gainers included Innovative Eyewear (LUCY) up 95.4%, Seer (SEER) up 37.66%, and Bristol-Myers Squibb Celegne Rights (CELGR) up 33.37%. Conversely, notable losers were SL Science Holding (SLBT) down 23.2%, Basel Medical Group (BMGL) down 14.62%, and BioXcel Therapeutics (BTAI) down 14.5%. The report highlights specific price movements and market capitalizations for these listed entities.
Gainers
- Innovative Eyewear (NASDAQ:LUCY) stock moved upwards by 95.4% to $1.49 during Monday's regular session. The market value of their outstanding shares is at $4.8 million.
- Seer (NASDAQ:SEER) shares rose 37.66% to $2.23. The company's market cap stands at $89.0 million.
- Bristol-Myers Squibb Company Celegne Contingent Value Rights (NYSE:CELGR) stock increased by 33.37% to $0.12.
- YD Bio (NASDAQ:YDES) stock rose 27.63% to $2.42. The market value of their outstanding shares is at $134.5 million.
- Axe Compute (NASDAQ:AGPU) stock moved upwards by 20.5% to $8.53. The market value of their outstanding shares is at $76.5 million.
- Celularity (NASDAQ:CELU) shares rose 19.95% to $0.74. The market value of their outstanding shares is at $17.6 million.
Losers
- SL Science Holding (NASDAQ:SLBT) stock decreased by 23.2% to $4.6 during Monday's regular session. The market value of their outstanding shares is at $3.3 billion.
- Basel Medical Group (NASDAQ:BMGL) stock declined by 14.62% to $7.13. The market value of their outstanding shares is at $13.0 million.
- BioXcel Therapeutics (NASDAQ:BTAI) stock declined by 14.5% to $1.18. The company's market cap stands at $42.6 million.
- Aktis Oncology (NASDAQ:AKTS) shares fell 13.84% to $27.36. The market value of their outstanding shares is at $1.7 billion.
- Universe Pharmaceuticals (NASDAQ:UPC) shares declined by 12.5% to $5.53. The company's market cap stands at $4.0 million.
- TransCode Therapeutics (NASDAQ:RNAZ) stock decreased by 12.32% to $7.55. The company's market cap stands at $8.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.